We’ve changed the way you complete courses
In response to user feedback we have simplified the way courses can be completed.
Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.
Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green ‘Mark complete’ button at the bottom of the page.
Once you have completed all of the topics in a module an assessment will be provided for you.
Complete all the assessments to finish the course.
Now that you have completed all of the topic areas in this module, you have an opportunity to take the end-of-module assessment. If you gain a score of 80% or above, you will have successfully completed the module and a certificate of completion will be generated for you to download for your own records. Links to your certificates of completion can be found on your ‘My account’ page.
If you do not achieve a score of 80%, you will be able to retake the assessment.
Assessment Summary
0 of 10 Questions completed
Questions:
Information
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
Results
Results
0 of 10 Questions answered correctly
Your time:
Time has elapsed
You have correctly answered 0 of 0 questions(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 10
1. Question
You are explaining how the SGLT-2 inhibitor class of drugs work to a person with diabetes, who wishes to know why these drugs might lower blood glucose.
Which of the following statements is the most appropriate information to give the patient with respect to the normal metabolism of glucose by the kidney?
(Select one answer only.)
CorrectIncorrect -
Question 2 of 10
2. Question
You are preparing a presentation to medical students around type 2 diabetes. As part of this presentation, you wish to explain the role of renal glucose homeostasis.
Which of the following is the most likely information to provide in your lecture?
(Select one answer only.)
CorrectIncorrect -
Question 3 of 10
3. Question
You are discussing the importance of the kidney in the pathogenesis of type 2 diabetes with a junior colleague.
Which of the following is the most appropriate to provide during this discussion?
(Select one answer only.)
CorrectIncorrect -
Question 4 of 10
4. Question
You are discussing the metabolic effects and mechanisms of action of SGLT-2 inhibitor therapy with a colleague.
Which of the following is the most appropriate statement?
(Select one answer only.)
CorrectIncorrect -
Question 5 of 10
5. Question
You are discussing the potential mechanisms accounting for the blood-pressure reduction associated with SGLT-2 inhibitor therapy with a junior colleague.
Which of the following statements contains the most appropriate information?
(Select one answer only.)
CorrectIncorrect -
Question 6 of 10
6. Question
You are discussing the history of development of SGLT-2 inhibitors with colleagues at a lunchtime meeting. SGLT-2 inhibitors are derived from the molecule phlorizin.
Which of the following is the most appropriate description of the effects of phlorizin?
(Select one answer only.)
CorrectIncorrect -
Question 7 of 10
7. Question
You are planning to initiate an SGLT-2 inhibitor in a patient with suboptimal glucose control on metformin monotherapy. Prior to commencing the medication, the patient wants to know more about possible benefits and side-effects of the treatment.
Which of the following is the most appropriate information during your discussion with this patient?
(Select one answer only.)
CorrectIncorrect -
Question 8 of 10
8. Question
You are explaining the glucose-lowering effects of an SGLT-2 inhibitor with colleagues.
Which of the following is the most appropriate statement?
(Select one answer only.)
CorrectIncorrect -
Question 9 of 10
9. Question
You are reviewing a 48-year-old man with a two-year history of type 2 diabetes in the clinic. He has a blood pressure of 156/79 mm/Hg and a body weight of 99 kg reflecting a BMI of 33 kg/m2. His most recent HbA1c is 71 mmol/mol, eGFR 75 ml/1.73 m2 and total cholesterol 4.4 mmol/l with an albumin-creatinine ratio of 4.1 mg/mmol. His current medication includes metformin 1 g once a day, ramipril 10 mg and atorvastatin 40 mg once a day.
Which of the following statements best describes the rationale for initiating an SGLT-2 inhibitor in his case?
(Select one answer only.)
CorrectIncorrect -
Question 10 of 10
10. Question
You are reviewing a 69-year-old woman with a 14-year history of type 2 diabetes. Her current medication includes metformin 1 g twice daily, simvastatin 40 mg once daily, lisinopril 10 mg once daily, insulin glargine 80 units once daily, insulin aspart 40 units with meals. Her HbA1c is 79 mmol/mol, blood pressure 160/80 mm/Hg, eGFR 75 ml/1.73 m2, urinary albumin-creatinine ratio 3.9 mg/mmol, total cholesterol 4.2 mmol/l, LDL cholesterol 2.9 mmol/l and HDL cholesterol 0.9 mmol/l.
Which of the following best describes the benefits of an SGLT-2 inhibitor in this woman’s case?
(Select one answer only.)
CorrectIncorrect